WHO H5 Reference Laboratories definition

WHO H5 Reference Laboratories means influenza laboratories that have been designated by WHO in order to strengthen national and regional capacity for reliably diagnosing H5 virus infection until this capacity is more widespread.
Sample 1Sample 2Sample 3
WHO H5 Reference Laboratories means influenza laboratories that have been designated by WHO in order to strengthen national and regional capacity for reliably diagnosing H5 virus infection until this capacity is more widespread; PIP (Fn. 85), 4.3 p. 10 et seq. WHO H5 Reference Laboratories are laboratories that were designated by WHO on an ad hoc basis commencing in 2005, to support the WHO GISRS in response to the emergence and spread of highly pathogenic avian influenza H5N1. These laboratories conduct influenza risk assessment and response by providing reliable laboratory diagnosis of influenza infection in humans, especially those suspected of being associated with avian influenza A (H5) viruses or other influenza viruses with pandemic potential (PIP (Fn. 85), Annex 5, p. 53). They provide laboratory services also to other countries when needed, provide expertise and laboratory support in response to an outbreak, share available gene sequences and build up scientific networks.
Sample 1Sample 2

Examples of WHO H5 Reference Laboratories in a sentence

  • For activities related to pandemic influenza, the [WHO Network] includes four complementary categories of institutions and laboratories: National Influenza Centres, WHO Collaborating Centres, WHO H5 Reference Laboratories and Essential Regulatory Laboratories.

  • For activities related to pandemic influenza, the WHO GISRS includes four complementary categories of institutions and laboratories: National Influenza Centres, WHO Collaborating Centres, WHO H5 Reference Laboratories and Essential Regulatory Laboratories.

  • WHO Collaborating Centres on Influenza and WHO H5 Reference Laboratories and the Director-General will actively continue to provide technical assistance to Member States to enhance research and surveillance capacity, including staff training, with the objective of improving national pandemic risk assessment and pandemic risk response.

  • WHO Collaborating Centres on Influenza, WHO H5 Reference Laboratories and Essential Regulatory Laboratories, working with the WHO Secretariat, will continue to make available to National Influenza Centres and Other authorized laboratories, without charge, supplies of noncommercial diagnostic reagents and test kits for the identification and characterization of clinical specimens of influenza.

  • The sharing of influenza viruses has occurred for almost 65 years through a WHO-coordinated global network of laboratories known as GISRS.32 GISRS comprises four different types of laboratories: National Influenza Centres (NICs), WHO Collaborating Centres (WHO CCs), WHO Essential Regulatory Laboratories (WHO ERLs), and WHO H5 Reference Laboratories, all of which operate under WHO Terms of Reference (TORs).

  • GISRS comprises four different types of laboratories: National Influenza Centres (NICs), WHO Collaborating Centres (WHO CCs), WHO Essential Regulatory Laboratories (WHO ERLs), and WHO H5 Reference Laboratories, all of which operate under WHO Terms of Reference (TORs).

  • WHO H5 Reference Laboratories are laboratories that were designated by WHO on an ad hoc basis commencing in 2005, to support the [WHO network] in response to the emergence and spread of highly pathogenic avian influenza H5N1.

  • WHO H5 Reference Laboratories – WHO H5 Reference Laboratories are designated by WHO to support the WHO GISRS in response to the emergence and spread of highly pathogenic avian influenza H5 subtype viruses.

  • Geneva: World Health Organization; 2011 (http://www.who.int/influenza/pip/en/, accessed 21 September 2016), Annex 5, WHO H5 Reference Laboratories, Core Terms of Reference, B.

  • By providing PIP biological materials from National Influenza Centres and Other authorized laboratories to WHO Collaborating Centres on Influenza and WHO H5 Reference Laboratories as set out in paragraph 5.1.1(i) above, Member States provide their [prior informed consent] / [consent] for the onward transfer and use of PIP biological materials to the institutions, organizations and entities [as set out in 5.1.1(ii)].

Related to WHO H5 Reference Laboratories

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Testing laboratory means a laboratory, facility, or entity in the state that offers or performs tests of cannabis or cannabis products and that is both of the following:

  • Participating Clinical Laboratory means a Clinical Laboratory which has a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.

  • Standard reference compendia means the American Medical Association Drug Evaluations, the

  • Pharmaceutical care means the provision of drug therapy and

  • veterinary surgeon means a veterinary surgeon within the meaning of the Veterinary Surgeons Act 1936.

  • Radiopharmaceutical quality assurance means, but is not limited to, the performance of appropriate chemical, biological, and physical tests on potential radiopharmaceuticals and the interpretation of the resulting data to determine their suitability for use in humans and animals, including internal test assessment, authentication of product history, and the keeping of proper records.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Analytical x-ray system means a group of components utilizing x-rays to determine the elemental composition or to examine the microstructure of materials.

  • Peer-reviewed medical literature means a published scientific study in a journal or other publication in which original manuscripts have been published only after having been critically reviewed for scientific accuracy, validity and reliability by unbiased independent experts, and that has been determined by the international committee of medical journal editors to have met the uniform requirements for manuscripts submitted to biomedical journals. Peer-reviewed medical literature does not include publications or supplements to publications that are sponsored to a significant extent by a pharmaceutical manufacturing company or health carrier.

  • Non-Participating Clinical Laboratory means a Clinical Laboratory which does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan provide services to you at the time services are rendered.

  • Diagnostic clinical procedures manual means a collection of written procedures that describes each method (and other instructions and precautions) by which the licensee performs diagnostic clinical procedures; where each diagnostic clinical procedure has been approved by the authorized user and includes the radiopharmaceutical, dosage, and route of administration.

  • Palliative and supportive care means care and support aimed mainly at lessening or controlling pain or symptoms; it makes no attempt to cure the Covered Person's terminal Illness or terminal Injury.

  • Diagnostic source assembly means the tube housing assembly with a beam-limiting device attached.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Clinical nurse specialist means a registered nurse with relevant post-basic qualifications and 12 months’ experience working in the clinical area of his/her specified post-basic qualification, or a minimum of four years’ post-basic registration experience, including three years’ experience in the relevant specialist field and who satisfies the local criteria.

  • Practice of medicine or osteopathic medicine means the prevention, diagnosis and treatment of

  • Independent testing laboratory means an independent organization, accepted by the Contracting Officer, engaged to perform specific inspections or tests of the work, either at the site or elsewhere, and report the results of these inspections or tests.

  • Therapeutic care means services provided by licensed or certified speech pathologists, Occupational Therapists and Physical Therapists.

  • Drug therapy management means the review of a drug therapy regimen of a patient by one or more pharmacists for the purpose of evaluating and rendering advice to one or more practitioners regarding adjustment of the regimen.

  • Three-dimensional reference system means a system as described in Appendix 2 to this annex;

  • Physical therapy licensing board or "licensing board" means the agency of a state that is responsible for the licensing and regulation of physical therapists and physical therapist assistants.

  • Diagnostic mammography means a method of screening that

  • National Ambient Air Quality Standards or “NAAQS” means national ambient air quality standards that are promulgated pursuant to Section 109 of the Act, 42 U.S.C. § 7409.

  • Therapeutic school means a residential group living facility:

  • Non-Participating Certified Clinical Nurse Specialist means a Certified Clinical Nurse Specialist who does not have a written agreement with the Claim Administrator or another Blue Cross and/or Blue Shield Plan to provide services to you at the time services are rendered.